These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Refsum's disease with severe neuropathy: efficiency of the diet and plasmapheresis]. Marroun I; Delèvaux I; André M; Droullé AG; Aumaître O Rev Med Interne; 2005 Jun; 26(6):523-5. PubMed ID: 15936485 [No Abstract] [Full Text] [Related]
6. Effect of phytanic acid on cultured retinal pigment epithelium: an in vitro model for Refsum's disease. Bernstein PS; Lloyd MB; O'Day WT; Bok D Exp Eye Res; 1992 Dec; 55(6):869-78. PubMed ID: 1283128 [TBL] [Abstract][Full Text] [Related]
7. Phytanic acid storage disease (Refsum's disease): clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management. Weinstein R J Clin Apher; 1999; 14(4):181-4. PubMed ID: 10611628 [TBL] [Abstract][Full Text] [Related]
8. [Pauci-symptomatic sensory polyneuropathy in Refsum's disease]. Lévy R; Verny M; Brault JL; Gugenheim M; Maisonobe T; Léger JM Rev Neurol (Paris); 1996; 152(6-7):469-72. PubMed ID: 8944245 [TBL] [Abstract][Full Text] [Related]
9. Lipapheresis: an immunoglobulin-sparing treatment for Refsum's disease. Gutsche HU; Siegmund JB; Hoppmann I Acta Neurol Scand; 1996 Sep; 94(3):190-3. PubMed ID: 8899052 [TBL] [Abstract][Full Text] [Related]